IMMUNOGLOBULIN DISEASE

Clinical trials for IMMUNOGLOBULIN DISEASE explained in plain language.

Never miss a new study

Get alerted when new IMMUNOGLOBULIN DISEASE trials appear

Sign up with your email to follow new studies for IMMUNOGLOBULIN DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Kidney disease drug faces Long-Term safety test

Disease control Recruiting now

This study follows patients who previously participated in zigakibart trials to monitor long-term safety and effectiveness for IgA nephropathy, a chronic kidney disease. About 220 adults will receive the drug every two weeks for up to two years while researchers track side effect…

Matched conditions: IMMUNOGLOBULIN DISEASE

Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

IMMUNOGLOBULIN DISEASE

Get alerted when new IMMUNOGLOBULIN DISEASE trials appear

Kidney disease drug faces Long-Term safety test